title: [Combination therapy for chronic viral hepatitis C].
authors.affiliation: Klinik für Innere Medizin II mit den Schwerpunkten Gastroenterologie, Hepatologie und Endokrinologie, Universitätskliniken des Saarlandes, Homburg/Saar. Zeuzem@uniklinik-saarland.de
authors.forename: S
authors.initials: S
authors.lastname: Zeuzem
mesh_terms: D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000009:adverse effects / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; D000547:Amantadine; C417083:peginterferon alfa-2b; C100416:peginterferon alfa-2a